3D Cell Culture Market is expected to register a CAGR close to 20.3% during 2018 – 2023 | Global Key Players – 3D BIOMATRIX, REINNERVATE, 3D BIOTEK, BECTON DICKINSON AND COMPANY, SIGMA ALDRICH CORPORATION, CORNING INCORPORATED

3D Cell Culture Market Overview
The global 3D Cell Culture market has been estimated to reach USD 682.8 million in 2017. The market is expected to register a CAGR of 20.3% during the forecast period, 2018 to 2023. North America dominates the market due to the incidence of cancer, and availability of well-established pharmaceutical and biotechnology industries.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16733
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Rising Need for Organ Transplantation
Cell culture is a process to grow prokaryotic cells or eukaryotic cells artificially, outside their natural environment, in a laboratory under controlled conditions. During the last decade, the demand for organ transplantation has increased, worldwide, due to increased incidences of organ failure, rise in success and improvement in post-transplant outcome. Increasing healthcare costs, aging population and rising prevalence of chronic disease that will continue to shape the industrial life science and thus majority of life science companies are investing in R&D sector.
Additionally, development of automated large-scale cell culture systems, use of 3D cell culture models, as an alternative tool in vivo testing and increasing focus on the regenerative medicine is also acting as a driver for Global 3D Cell Culture Market.

Key Developments in the Market
• October 2017: A partnership between Insphero AG and Charles River Laboratories International Inc.
• May 2017: 3D Biotek got FDA approval for 3D Cell Expansion System (3D-CES) as a medical device.

Key Players:
3D BIOMATRIX, REINNERVATE LTD, 3D BIOTEK LLC, BECTON DICKINSON AND COMPANY, SIGMA ALDRICH CORPORATION, CORNING INCORPORATED, THERMO FISHER SCIENTIFIC, GLOBAL CELL SOLUTIONS INC., NANOFIBER SOLUTIONS INCORPORATION, INSPHERO AG, LONZA GROUP, NANO 3D BIOSCIENCES.

Request Discount on this repots @ https://marketprognosis.com/discount-request/16733
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Budget Restriction for Small and Medium Sized Laboratories
3D hydrogels in cell culture market face challenges that have been hindering the market growth over the years. There hindrances include financial challenges by small & medium biotechnology and pharmaceutical companies. The initial investment, associated with 3D hydrogels in cell culture, is high. Moreover, organizations, operating at small or medium scale, are unable to bear the expenditure. This factor is the major restraint to the market growth. The application in developing countries of new biotechnology in cell culture and others areas will result in demand of experienced and skilled professionals and thus lack of skilled professionals for the 3D cell culture is also restraining the growth of 3D Cell Culture Market.
In addition, lack of consistency in 3D Cell Culture Products and Stringent Process Controls for advanced handling capabilities is also hindering the market.

North America to Dominate the Market
The market has been segmented on the basis of technology, application, end-user, and geography. Based on technology, the market has been segmented into extracellular matrices (scaffolds), bioreactors, gels, scaffold-free platforms, microchips, and others. The market, based on application, has been divided into research, drug discovery, tissue engineering, clinical applications, stem cell biology, and others. On the basis of end user, the market has been segregated into research laboratories and institutes, biotechnology and pharmaceutical industries, hospitals and diagnostic centers, and others. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the 3D Cell Culture market due to the due to the incidence of cancer, and availability of well-established pharmaceutical and biotechnology industries which are investing in the R&D projects carried out which results in the high demand in that region.

Enquiry Before Buying @ https://marketprognosis.com/enquiry/16733
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.